Pharmaceuticals, Biotechnology and Life Sciences
– Data demonstrated that once-weekly TransCon CNP has the potential to meet patient and caregiver needs for a safe, effective,…
ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”),…
Martine Clozel was selected for the Prix Suisse award for her contribution to research, science, and medicine and was presented…
Robust reductions in plasma kallikrein levels and HAE attack rates observed at all doses testedAll patients treated in the 25…
VANCOUVER, British Columbia, Nov. 11, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
SILICON VALLEY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, announces the introduction of PredicineCOMPLETE™,…
MONTRÉAL, Nov. 10, 2022 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its…
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing…
ZUG, Switzerland and BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating…
Company on-track to initiate Phase 3 clinical trials of TTP399 in the first quarter of 2023 Industry veteran Paul Sekhri…